Selected article for: "clinical characteristic and early clinical characteristic"
Author: Qilin Li; Xiuli Ding; Geqing Xia; Zhi Geng; Fenghua Chen; Lin Wang; Zheng Wang
Title: A simple laboratory parameter facilitates early identification of COVID-19 patients
  • Document date: 2020_2_17
    • ID: hlhfx3fm_9
    Snippet: Since the data was collected at patients' first medical visit, eosinopenia was presumed to be an early event in patients' clinical course, possibly prior to emergence of characteristic radiological findings. Combined with fever and respiratory symptoms, eosinopenia as a parameter in routine blood tests might be capable of facilitating rapid identification of highlysuspected cases from mixed patients at triage in fever clinics. These quickly-ident.....
    Document: Since the data was collected at patients' first medical visit, eosinopenia was presumed to be an early event in patients' clinical course, possibly prior to emergence of characteristic radiological findings. Combined with fever and respiratory symptoms, eosinopenia as a parameter in routine blood tests might be capable of facilitating rapid identification of highlysuspected cases from mixed patients at triage in fever clinics. These quickly-identified suspected patients would be recommended to (1) receive the priority for radio-diagnosis and laboratory-definitive diagnosis, (2) be isolated in designated wards without any delay to avoid potential virus spreading, (3) and receive empirical antiviral treatment (as of now no consensus All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • antiviral treatment and clinical course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral treatment and early event: 1
    • antiviral treatment and empirical antiviral treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antiviral treatment and empirical antiviral treatment receive: 1
    • antiviral treatment and fever clinic: 1
    • blood test and clinical course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • blood test and fever clinic: 1, 2, 3, 4
    • blood test and mixed patient: 1
    • clinical course and early event: 1
    • clinical course and empirical antiviral treatment: 1
    • clinical course and fever clinic: 1
    • clinical course and mixed patient: 1